New and Novel Schizophrenia Treatment Paradigms: Moving Beyond Post-Synaptic Dopamine Modulation

Поділитися
Вставка
  • Опубліковано 28 вер 2024
  • A new era of novel treatments is dawning for people living with schizophrenia. Drs. Christoph U. Correll of Zucker School of Medicine at Hofstra/Northwell, Jonathan M. Meyer of UC San Diego and Leslie Citrome of New York Medical College talk about incorporating new agents into current treatment paradigms.
    This video is part of a larger CE/CME Certified program entitled: Schizophrenia: A Promising Treatment Era Dawns. You can receive free CME credit, view this video, and download slides from the presentation at www.mededonthe...

КОМЕНТАРІ • 18

  • @SusanAzoulayF
    @SusanAzoulayF 4 місяці тому

    Why is this not going viral?

  • @jinujoy9795
    @jinujoy9795 Рік тому +11

    Total cure will emerge one day

    • @bearclaus2676
      @bearclaus2676 9 місяців тому

      The problem is people who descend into madness lack or lose logical thinking.
      No amount of medication will fix attitudes, the religious brain or fantasy thinking.

  • @originate2464
    @originate2464 7 місяців тому +3

    Some things that seem like negative symptoms might sometimes be due to dopamine blocking medications

  • @rebeccamiller42
    @rebeccamiller42 9 місяців тому +3

    With KarXT, isn’t there a disconnect with brain and body? Don’t they have to add something in to not affect body receptors, only brain receptors? It would be nice to have a truly weight neutral medicine. I’ve gained 135 lbs and only 4’11” so it bothers me. I used to love to exercise. Also, I wish something could be discovered which heals brain from long term marijuana usage. Probably destroyed some pathway. Antipsychotics also somewhat dim the light in the soul and cause dependency so they make the disease progressively worse. I wish for a miracle med.

  • @jeanpaultongeren125
    @jeanpaultongeren125 10 місяців тому +2

    We need KarXT psychotic drug. because it's so good

  • @nagarjunakallathur6270
    @nagarjunakallathur6270 Рік тому +3

    When India Market available this medicine

  • @patrickm1666
    @patrickm1666 2 місяці тому

    Will there be more schizophrenia trials for ulotaront? Hoping they can turn it around for the drug.

  • @Sentinelfoodcourtracer
    @Sentinelfoodcourtracer 10 місяців тому +3

    Thanks for your research and clinical work! I participated in about 6 studies with Harvard University Psychiatry/Schizophrenia. They occurred at BIDMC, McLean Hospital, MGH. Many hours in fMRI, neuropsychological matrix, survey, and modal tx. Two studies of TMS for Schizophrenia. Not easy. Thanks a million + 1. ❤

  • @jeanpaultongeren125
    @jeanpaultongeren125 10 місяців тому +1

    We need KarXT

  • @DanC666_
    @DanC666_ 9 місяців тому

    Brilaroxazine worthy

  • @constantinhaller4391
    @constantinhaller4391 Рік тому +1

    Trospium has alot of sideffects. It has a Long Long Long List of severe side effects.

    • @Lipolimtown
      @Lipolimtown Рік тому +1

      I’ve heard a lot of things about KARxt and comparatively betel nut areca chew I have never really heard that Troposium specifically has a lot of side effects. What are they?
      I just wonder truly how effective KARxt is for negative symptoms and fatigue, enhancing personality, quality of life? I read somewhere that they don’t think it would work for primary negative symptoms but also wonder if it would work for the behavioral part of addictive disorders, addictive thinking and maybe enhance creativity? All in all It does sound like a deeply complex multifaceted drug and hope that is the case

    • @constantinhaller4391
      @constantinhaller4391 Рік тому

      @@Lipolimtownulotaront was suppost to help With fatique But it failed Last Month :(